| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | 6.77e-05 | 614 | 72 | 10 | GO:0140657 | |
| GeneOntologyCellularComponent | rDNA heterochromatin | 1.16e-04 | 5 | 72 | 2 | GO:0033553 | |
| Domain | ALMS_motif | 4.14e-05 | 3 | 70 | 2 | IPR029299 | |
| Domain | ALMS_motif | 4.14e-05 | 3 | 70 | 2 | PF15309 | |
| Domain | Integrin_alpha_C_CS | 1.61e-03 | 16 | 70 | 2 | IPR018184 | |
| Domain | Integrin_alpha-2 | 2.04e-03 | 18 | 70 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 2.04e-03 | 18 | 70 | 2 | PF08441 | |
| Domain | Integrin_alpha | 2.04e-03 | 18 | 70 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 2.04e-03 | 18 | 70 | 2 | PS00242 | |
| Domain | Int_alpha_beta-p | 2.27e-03 | 19 | 70 | 2 | IPR013519 | |
| Domain | Int_alpha | 2.27e-03 | 19 | 70 | 2 | SM00191 | |
| Domain | FG_GAP | 3.05e-03 | 22 | 70 | 2 | PS51470 | |
| Domain | FG-GAP | 3.62e-03 | 24 | 70 | 2 | PF01839 | |
| Domain | FG-GAP | 3.62e-03 | 24 | 70 | 2 | IPR013517 | |
| Domain | Integrin_dom | 3.93e-03 | 25 | 70 | 2 | IPR032695 | |
| Domain | P-loop_NTPase | 4.27e-03 | 848 | 70 | 9 | IPR027417 | |
| Domain | zf-C2H2_6 | 6.46e-03 | 314 | 70 | 5 | PF13912 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 9.04e-05 | 129 | 50 | 5 | M39693 | |
| Pathway | BIOCARTA_CREM_PATHWAY | 1.83e-04 | 6 | 50 | 2 | MM1538 | |
| Pathway | BIOCARTA_CREM_PATHWAY | 1.83e-04 | 6 | 50 | 2 | M22012 | |
| Pubmed | CASP8AP2 GUF1 R3HCC1L BAZ2A ATAD5 EIF2S1 GLG1 ZNF644 SYNE2 RRP8 CKAP2 SLC39A10 CACYBP SEC63 HSPA4 PUS7 CXADR | 8.87e-09 | 1487 | 73 | 17 | 33957083 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 SETD2 TIMM9 SETX ZBED4 BAZ2A ATAD5 PHF3 ZNF644 UBQLN4 PAXIP1 ACIN1 ZFR RRP8 CKAP2 | 6.41e-08 | 1294 | 73 | 15 | 30804502 |
| Pubmed | SOX9 CASP8AP2 SETD2 ATAD5 PHF3 EIF2S1 TCEAL4 ACIN1 ZFR XPO1 CACYBP CCNK PUS7 | 1.74e-07 | 1014 | 73 | 13 | 32416067 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SETD2 R3HCC1L BAZ2A ATAD5 ACIN1 ZFR CKAP2 CACYBP CCNK HSPA4 PUS7 ANAPC4 | 5.36e-07 | 934 | 73 | 12 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SETD2 SETX BAZ2A ATAD5 PHF3 ZNF644 ACIN1 ZFR RRP8 CCNK KIF20B ANAPC4 | 6.69e-07 | 954 | 73 | 12 | 36373674 |
| Pubmed | SETX RASA2 GLG1 ACIN1 CEP295 TSTD2 CKAP2 SLC39A10 FCHO2 SEC63 POLK NCKAP1L | 2.52e-06 | 1084 | 73 | 12 | 11544199 | |
| Pubmed | 3.18e-06 | 14 | 73 | 3 | 38237591 | ||
| Pubmed | C4orf17 FILIP1 KIF18A SYNE2 ZNF571 AASDH CKAP2 FCHO2 ZNF700 KIF20B | 3.74e-06 | 750 | 73 | 10 | 11230166 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 4.16e-06 | 759 | 73 | 10 | 35915203 | |
| Pubmed | 4.74e-06 | 116 | 73 | 5 | 30804394 | ||
| Pubmed | EIF2S1 GLG1 PITX2 ZFR CKAP2 CACYBP SEC63 CCNK HSPA4 ANAPC4 NCKAP1L | 5.57e-06 | 971 | 73 | 11 | 33306668 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | KIF18A PHF3 EIF2S1 ACIN1 ZFR RRP8 XPO1 SLC39A10 SEC63 HSPA4 KIF20B | 6.62e-06 | 989 | 73 | 11 | 36424410 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | IGF1R CD9 PHF3 GLG1 ZNF644 ITGA6 XPO1 SLC39A10 SEC63 ZNF160 CXADR ANAPC4 | 7.28e-06 | 1203 | 73 | 12 | 29180619 |
| Pubmed | 7.53e-06 | 222 | 73 | 6 | 37071664 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PHF3 EIF2S1 DDX60 ITGA6 ACIN1 ZFR RRP8 XPO1 CKAP2 CACYBP SEC63 KIF20B | 1.13e-05 | 1257 | 73 | 12 | 36526897 |
| Pubmed | KIF18A MTUS1 ATAD5 SYNE2 ITGA6 XPO1 CKAP2 SLC39A10 FCHO2 CACYBP CXADR | 1.15e-05 | 1049 | 73 | 11 | 27880917 | |
| Pubmed | GUF1 SETD2 SETX BAZ2A ATAD5 PHF3 EIF2S1 GLG1 RRP8 CKAP2 SEC63 CCNK KIF20B | 1.28e-05 | 1497 | 73 | 13 | 31527615 | |
| Pubmed | PITX2 associates with PTIP-containing histone H3 lysine 4 methyltransferase complex. | 1.30e-05 | 3 | 73 | 2 | 24486544 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34600083 | ||
| Pubmed | Requirement of CD9 on the egg plasma membrane for fertilization. | 1.30e-05 | 3 | 73 | 2 | 10634791 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28939775 | ||
| Pubmed | CREM-dependent transcription in male germ cells controlled by a kinesin. | 1.30e-05 | 3 | 73 | 2 | 12493914 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 10711425 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18032737 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22495974 | ||
| Pubmed | Expression of the transcription factors Otlx2, Barx1 and Sox9 during mouse odontogenesis. | 1.30e-05 | 3 | 73 | 2 | 9541211 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 9698453 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 20844083 | ||
| Pubmed | SETX DOCK8 EIF2S1 ZNF644 PAXIP1 ZFR AASDH XPO1 CACYBP CCNK HSPA4 | 1.83e-05 | 1103 | 73 | 11 | 34189442 | |
| Pubmed | 2.39e-05 | 407 | 73 | 7 | 12693553 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 8838570 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 15679046 | ||
| Pubmed | New gene functions in megakaryopoiesis and platelet formation. | 2.63e-05 | 81 | 73 | 4 | 22139419 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.26e-05 | 588 | 73 | 8 | 38580884 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.48e-05 | 774 | 73 | 9 | 15302935 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 16418227 | ||
| Pubmed | Primordial germ cell DNA demethylation and development require DNA translesion synthesis. | 4.33e-05 | 5 | 73 | 2 | 38702312 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 30576429 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 33135541 | ||
| Pubmed | 4.72e-05 | 453 | 73 | 7 | 29656893 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 12883474 | ||
| Pubmed | CD36 associates with CD9 and integrins on human blood platelets. | 6.48e-05 | 6 | 73 | 2 | 11238109 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 28873464 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 1690718 | ||
| Pubmed | 6.75e-05 | 103 | 73 | 4 | 10574462 | ||
| Pubmed | 6.80e-05 | 653 | 73 | 8 | 22586326 | ||
| Pubmed | Integrin expression patterns during early limb muscle development in the mouse. | 9.06e-05 | 7 | 73 | 2 | 14516674 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 11767049 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 16537545 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 9360996 | ||
| Pubmed | 9.42e-05 | 506 | 73 | 7 | 30890647 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GUF1 SETX RASA2 BAZ2A EIF2S1 ACIN1 RIOK3 ZFR XPO1 HSPA4 KIF20B | 1.15e-04 | 1353 | 73 | 11 | 29467282 |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 9553049 | ||
| Pubmed | Developmental regulation of integrin expression at the time of implantation in the mouse embryo. | 1.21e-04 | 8 | 73 | 2 | 8306881 | |
| Pubmed | Expression of beta 1 integrin complexes on the surface of unfertilized mouse oocyte. | 1.21e-04 | 8 | 73 | 2 | 7691492 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MTUS1 GLG1 TCEAL4 SYNE2 ITGA6 ACIN1 ZFR XPO1 CACYBP HSPA4 PUS7 | 1.26e-04 | 1367 | 73 | 11 | 32687490 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.30e-04 | 370 | 73 | 6 | 22922362 | |
| Pubmed | Characterization of integrin engagement during defined human embryonic stem cell culture. | 1.55e-04 | 9 | 73 | 2 | 19933311 | |
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 1693624 | ||
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 10094488 | ||
| Pubmed | Mechanisms controlling the temporal degradation of Nek2A and Kif18A by the APC/C-Cdc20 complex. | 1.55e-04 | 9 | 73 | 2 | 23288039 | |
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 25808196 | ||
| Pubmed | Dental niche cells directly contribute to tooth reconstitution and morphogenesis. | 1.55e-04 | 9 | 73 | 2 | 36476878 | |
| Pubmed | 1.56e-04 | 549 | 73 | 7 | 38280479 | ||
| Pubmed | 1.76e-04 | 132 | 73 | 4 | 26439863 | ||
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 24753544 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | KIF18A IGF1R GLG1 ITGA6 ITGA1 CKAP2 SLC39A10 CACYBP SEC63 CXADR | 2.00e-04 | 1201 | 73 | 10 | 35696571 |
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 20878950 | ||
| Pubmed | Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse. | 2.36e-04 | 11 | 73 | 2 | 15739233 | |
| Pubmed | Immunolocalization of extracellular matrix components and integrins during mouse liver development. | 2.36e-04 | 11 | 73 | 2 | 15368439 | |
| Pubmed | 2.61e-04 | 421 | 73 | 6 | 36976175 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | GUF1 TIMM9 BAZ2A ZNF644 SYNE2 ZFR R3HDM2 RRP8 CKAP2 CACYBP SEC63 | 2.75e-04 | 1496 | 73 | 11 | 32877691 |
| Pubmed | Meta-analysis identifies six new susceptibility loci for atrial fibrillation. | 2.83e-04 | 12 | 73 | 2 | 22544366 | |
| Pubmed | 2.83e-04 | 12 | 73 | 2 | 24381169 | ||
| Pubmed | Identification and Herc5-mediated ISGylation of novel target proteins. | 2.83e-04 | 12 | 73 | 2 | 16884686 | |
| Pubmed | Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells. | 2.83e-04 | 12 | 73 | 2 | 28580283 | |
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 2.87e-04 | 150 | 73 | 4 | 22678362 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.90e-04 | 608 | 73 | 7 | 36089195 | |
| Pubmed | 2.98e-04 | 277 | 73 | 5 | 30745168 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 3.18e-04 | 1038 | 73 | 9 | 26673895 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.29e-04 | 283 | 73 | 5 | 30585729 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 3.30e-04 | 440 | 73 | 6 | 34244565 | |
| Pubmed | Testis determination requires insulin receptor family function in mice. | 3.34e-04 | 13 | 73 | 2 | 14628051 | |
| Pubmed | 3.34e-04 | 13 | 73 | 2 | 25746793 | ||
| Pubmed | 3.34e-04 | 13 | 73 | 2 | 20563599 | ||
| Pubmed | Genetic studies on the functional relevance of the protein prenyltransferases in skin keratinocytes. | 3.89e-04 | 14 | 73 | 2 | 20106865 | |
| Pubmed | 3.89e-04 | 14 | 73 | 2 | 29273440 | ||
| Pubmed | Spatiotemporal role of SETD2-H3K36me3 in murine pancreatic organogenesis. | 3.89e-04 | 14 | 73 | 2 | 38265933 | |
| Pubmed | SOX9 modulates the expression of key transcription factors required for heart valve development. | 3.89e-04 | 14 | 73 | 2 | 26525672 | |
| Pubmed | 4.48e-04 | 15 | 73 | 2 | 21379568 | ||
| Pubmed | Synaptotagmin-13 orchestrates pancreatic endocrine cell egression and islet morphogenesis. | 4.48e-04 | 15 | 73 | 2 | 35927244 | |
| Pubmed | Loss of Axin2 Causes Ocular Defects During Mouse Eye Development. | 4.48e-04 | 15 | 73 | 2 | 27701636 | |
| Pubmed | Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. | 4.48e-04 | 15 | 73 | 2 | 11092755 | |
| Pubmed | 4.48e-04 | 15 | 73 | 2 | 15366018 | ||
| Pubmed | 4.78e-04 | 472 | 73 | 6 | 38943005 | ||
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 5.12e-04 | 16 | 73 | 2 | 12904471 | |
| Pubmed | 5.79e-04 | 17 | 73 | 2 | 28327634 | ||
| Pubmed | Focal adhesion kinase-mediated signaling controls the onset of pancreatic cell differentiation. | 5.79e-04 | 17 | 73 | 2 | 36017799 | |
| Pubmed | 6.07e-04 | 494 | 73 | 6 | 26831064 | ||
| Pubmed | m6A RNA methylation impacts fate choices during skin morphogenesis. | 6.51e-04 | 18 | 73 | 2 | 32845239 | |
| Interaction | TERF2IP interactions | SETD2 SETX BAZ2A ATAD5 PHF3 ZNF644 XPO1 PEA15 HSPA4 KIF20B PUS7 ANAPC4 | 4.65e-07 | 552 | 71 | 12 | int:TERF2IP |
| Interaction | MIS12 interactions | 1.55e-05 | 89 | 71 | 5 | int:MIS12 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 9.85e-04 | 18 | 47 | 2 | 1160 | |
| GeneFamily | DNA polymerases | 1.62e-03 | 23 | 47 | 2 | 535 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 KIF18A SETX MTUS1 PHF3 TCEAL4 ZNF644 SYNE2 ITGA6 XPO1 SEC63 ZNF700 POLQ POLK KIF20B | 3.07e-10 | 656 | 73 | 15 | M18979 |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_DN | 2.02e-06 | 74 | 73 | 5 | M42506 | |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 6.59e-06 | 164 | 73 | 6 | M19957 | |
| Coexpression | FOROUTAN_TGFB_EMT_DN | 1.30e-05 | 108 | 73 | 5 | M42502 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 2.51e-05 | 705 | 73 | 10 | M1410 | |
| Coexpression | LEE_BMP2_TARGETS_DN | CASP8AP2 TIMM9 ATAD5 EIF2S1 PAXIP1 RIOK3 RRP8 XPO1 CACYBP LY75 HSPA4 | 3.90e-05 | 904 | 73 | 11 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | CASP8AP2 TIMM9 ATAD5 EIF2S1 PAXIP1 RIOK3 RRP8 XPO1 CACYBP LY75 HSPA4 | 4.66e-05 | 922 | 73 | 11 | MM1068 |
| Coexpression | VANGURP_PANCREATIC_DELTA_CELL | 5.79e-05 | 75 | 73 | 4 | M45032 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3 | 7.61e-05 | 5 | 73 | 2 | M1371 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3 | 7.61e-05 | 5 | 73 | 2 | MM577 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CASP8AP2 KIF18A DDX60 PAXIP1 ZFR ITGA1 XPO1 CKAP2 SLC39A10 CACYBP POLQ KIF20B PUS7 | 1.23e-04 | 1407 | 73 | 13 | M14427 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.26e-04 | 856 | 73 | 10 | M4500 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.29e-04 | 402 | 73 | 7 | MM454 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | 1.30e-04 | 694 | 73 | 9 | M45767 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 1.45e-04 | 550 | 73 | 8 | M16189 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | 1.87e-04 | 571 | 73 | 8 | MM1100 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_CIRCRNA_GENES | 1.90e-04 | 40 | 73 | 3 | MM17488 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 2.11e-04 | 194 | 73 | 5 | M2517 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SETD2 SETX RASA2 DOCK8 PHF3 GLG1 ZNF644 ZFR ITGA1 XPO1 CKAP2 CACYBP NCKAP1L | 2.20e-04 | 1492 | 73 | 13 | M40023 |
| Coexpression | GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP | 2.21e-04 | 196 | 73 | 5 | M3148 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 2.26e-04 | 197 | 73 | 5 | M9916 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN | 2.37e-04 | 199 | 73 | 5 | M8109 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 2.37e-04 | 199 | 73 | 5 | M5620 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP | 2.43e-04 | 200 | 73 | 5 | M4617 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP | 2.43e-04 | 200 | 73 | 5 | M6352 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_UP | 2.43e-04 | 200 | 73 | 5 | M3423 | |
| Coexpression | GSE3982_NKCELL_VS_TH2_DN | 2.43e-04 | 200 | 73 | 5 | M5598 | |
| Coexpression | COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP | 2.47e-04 | 109 | 73 | 4 | M18762 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CASP8AP2 KIF18A ATAD5 SYNE2 ITGA6 CEP295 XPO1 CKAP2 POLQ KIF20B | 2.67e-04 | 939 | 73 | 10 | M45768 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 3.04e-04 | 210 | 73 | 5 | MM958 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SOX9 CASP8AP2 KIF18A SETX R3HCC1L ZBED4 ATAD5 EIF2S1 ZNF644 SYNE2 CEP295 PWWP3B XPO1 CCDC122 SLC39A10 FCHO2 CACYBP ZNF160 HSPA4 KIF20B | 3.65e-09 | 1252 | 72 | 20 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX9 CASP8AP2 KIF18A SETX ZBED4 ATAD5 PHF3 EIF2S1 ZNF644 SYNE2 PAXIP1 CEP295 PWWP3B XPO1 CACYBP SEC63 ZNF160 CCNK HSPA4 KIF20B | 3.90e-09 | 1257 | 72 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX9 CASP8AP2 KIF18A SETX ZBED4 ATAD5 PHF3 EIF2S1 ZNF644 SYNE2 PITX2 PAXIP1 CEP295 PWWP3B XPO1 CACYBP SEC63 ZNF160 CCNK HSPA4 KIF20B | 8.50e-09 | 1459 | 72 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CASP8AP2 KIF18A SETX ZBED4 ATAD5 PHF3 PAXIP1 ACIN1 POLQ CCNK HSPA4 KIF20B | 2.12e-07 | 532 | 72 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | CASP8AP2 KIF18A SETX ATAD5 EIF2S1 ZNF644 PITX2 CEP295 C10orf90 PWWP3B CKAP2 CCDC122 FCHO2 CACYBP SEC63 ZNF160 HSPA4 KIF20B ANAPC4 | 2.75e-07 | 1468 | 72 | 19 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.82e-07 | 192 | 72 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CASP8AP2 KIF18A SETX ATAD5 EIF2S1 ZNF644 CEP295 PWWP3B CKAP2 CCDC122 FCHO2 CACYBP SEC63 ZNF160 HSPA4 KIF20B ANAPC4 | 6.16e-07 | 1241 | 72 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.03e-05 | 311 | 72 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX9 CASP8AP2 KIF18A ZBED4 ATAD5 PHF3 SYNE2 ZFR CEP295 AASDH PWWP3B PEA15 HSPA4 KIF20B CXADR | 4.56e-05 | 1370 | 72 | 15 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SOX9 CASP8AP2 KIF18A SETX ZBED4 ATAD5 ZNF644 SYNE2 CEP295 CACYBP HSPA4 KIF20B CXADR | 5.06e-05 | 1060 | 72 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | GUF1 SETD2 R3HCC1L ZNF644 SYNE2 R3HDM2 SEC63 ZNF700 POLK HSPA4 KIF20B | 5.99e-05 | 780 | 72 | 11 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 KIF18A SETD2 R3HCC1L ATAD5 SYNE2 R3HDM2 CEP295 POLQ HSPA4 KIF20B | 1.05e-04 | 831 | 72 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | CASP8AP2 KIF18A ATAD5 EIF2S1 PAXIP1 AASDH XPO1 CACYBP CCNK HSPA4 KIF20B PUS7 CXADR | 1.30e-04 | 1164 | 72 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | CASP8AP2 KIF18A GRTP1 ZBED4 ATAD5 EIF2S1 PAXIP1 RRP8 XPO1 CACYBP ZNF700 HSPA4 KIF20B CXADR | 1.78e-04 | 1371 | 72 | 14 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.85e-04 | 469 | 72 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SOX9 FILIP1 CASP8AP2 KIF18A SETX ZBED4 ATAD5 ZNF644 SYNE2 CEP295 CACYBP HSPA4 KIF20B CXADR | 2.46e-04 | 1414 | 72 | 14 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.78e-04 | 498 | 72 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.45e-04 | 98 | 72 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_500 | 4.49e-04 | 105 | 72 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CASP8AP2 KIF18A SETD2 ATAD5 EIF2S1 SYNE2 CEP295 CACYBP POLQ HSPA4 KIF20B | 4.72e-04 | 989 | 72 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 4.76e-04 | 410 | 72 | 7 | GSM791122_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | CASP8AP2 KIF18A ATAD5 EIF2S1 PAXIP1 AASDH XPO1 CACYBP CCNK HSPA4 KIF20B PUS7 CXADR | 5.39e-04 | 1347 | 72 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 5.65e-04 | 422 | 72 | 7 | GSM538357_500 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.29e-11 | 200 | 73 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.34e-09 | 199 | 73 | 8 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.34e-09 | 199 | 73 | 8 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.76e-08 | 190 | 73 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.79e-08 | 199 | 73 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-07 | 169 | 73 | 6 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-07 | 178 | 73 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-07 | 187 | 73 | 6 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.73e-07 | 193 | 73 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.24e-07 | 199 | 73 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.51e-07 | 200 | 73 | 6 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.51e-07 | 200 | 73 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.51e-07 | 200 | 73 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.51e-07 | 200 | 73 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.67e-06 | 165 | 73 | 5 | 1d0f60bf47a40ac916f0fcb5532a968742a0edbb | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-06 | 166 | 73 | 5 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.61e-06 | 169 | 73 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-06 | 172 | 73 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-06 | 174 | 73 | 5 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 180 | 73 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 180 | 73 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.27e-05 | 183 | 73 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 184 | 73 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 185 | 73 | 5 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.37e-05 | 186 | 73 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 187 | 73 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 187 | 73 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 187 | 73 | 5 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 187 | 73 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 187 | 73 | 5 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 187 | 73 | 5 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.48e-05 | 189 | 73 | 5 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.48e-05 | 189 | 73 | 5 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-05 | 189 | 73 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-05 | 191 | 73 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.63e-05 | 193 | 73 | 5 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.68e-05 | 194 | 73 | 5 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.72e-05 | 195 | 73 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.72e-05 | 195 | 73 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.72e-05 | 195 | 73 | 5 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 195 | 73 | 5 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.72e-05 | 195 | 73 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 196 | 73 | 5 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.76e-05 | 196 | 73 | 5 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.76e-05 | 196 | 73 | 5 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.76e-05 | 196 | 73 | 5 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 196 | 73 | 5 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 196 | 73 | 5 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.80e-05 | 197 | 73 | 5 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 197 | 73 | 5 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-05 | 197 | 73 | 5 | 6de02b02fcdfcab1c1b0f4a4c75677410bc55688 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 197 | 73 | 5 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 197 | 73 | 5 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 1.80e-05 | 197 | 73 | 5 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.85e-05 | 198 | 73 | 5 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.85e-05 | 198 | 73 | 5 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-05 | 198 | 73 | 5 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.85e-05 | 198 | 73 | 5 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 199 | 73 | 5 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.89e-05 | 199 | 73 | 5 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | distal-Hematologic-Proliferating_NK/T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-05 | 199 | 73 | 5 | 4f02e03c118744fba0dfc5e3ed6dea4041f3d089 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 73 | 5 | 0eccf41edefc3b8b5d0316f57d5ba572949aec2b | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 73 | 5 | 535f6fba8d03873ba35c9949579161dc41cd7a60 | |
| ToppCell | Severe_COVID-19-T/NK-proliferating_T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.94e-05 | 200 | 73 | 5 | 52265e761a961f3724b388285e0919bd58847138 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 73 | 5 | 98d7f577b31a603bf835bf9b4ea31999445cf0e5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-05 | 200 | 73 | 5 | 3c3ac587ad98e3f6be809eac18c7742a23140de1 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.94e-05 | 200 | 73 | 5 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-05 | 200 | 73 | 5 | 5c84aaedac9f27da0da0493dab7c8f7a4d66888c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-05 | 200 | 73 | 5 | 60d11275f06490f86f400a2802492f9c1b570400 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 1.94e-05 | 200 | 73 | 5 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 73 | 5 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.94e-05 | 200 | 73 | 5 | dd7ad295ab3ba4c19babffb1625900db414bb5a9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 200 | 73 | 5 | 63f9481059be608ddc9fe9c7a8f8503fce9755dd | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.94e-05 | 200 | 73 | 5 | 0e44a55d65b72eb40543d3bde301f8598ac251c3 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.94e-05 | 200 | 73 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | distal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | 1b65c97e8123d0572d31525d6a10bc7f16857959 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.94e-05 | 200 | 73 | 5 | b239c711cce967826432fdbd5f88eba98a88bb0c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 73 | 5 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.39e-05 | 131 | 73 | 4 | d5bc40cd585582856881081b7130dec3515b4ae0 | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 157 | 73 | 4 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 158 | 73 | 4 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 158 | 73 | 4 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 158 | 73 | 4 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 163 | 73 | 4 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 165 | 73 | 4 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 167 | 73 | 4 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 167 | 73 | 4 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.67e-04 | 168 | 73 | 4 | 5e721268f0baa51d3f640f7f4c41db769ebef210 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 168 | 73 | 4 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.85e-05 | 50 | 46 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.83e-06 | 183 | 72 | 7 | 1709_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.99e-06 | 197 | 72 | 7 | 4831_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 3.00e-05 | 189 | 72 | 6 | 6649_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 3.09e-05 | 190 | 72 | 6 | 4507_DN | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.37e-05 | 193 | 72 | 6 | 4951_DN | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 3.47e-05 | 194 | 72 | 6 | 1147_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.47e-05 | 194 | 72 | 6 | 3606_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A | 3.57e-05 | 195 | 72 | 6 | 4508_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 3.67e-05 | 196 | 72 | 6 | 2119_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.78e-05 | 197 | 72 | 6 | 3404_DN | |
| Disease | mean platelet volume | SETD2 GRTP1 CD9 ZBED4 BAZ2A DOCK8 ATAD5 SYNE2 AFF3 ITGA6 FCHO2 LY75 | 3.34e-06 | 1020 | 68 | 12 | EFO_0004584 |
| Disease | Paroxysmal atrial fibrillation | 3.09e-05 | 156 | 68 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 3.09e-05 | 156 | 68 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.09e-05 | 156 | 68 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 3.48e-05 | 160 | 68 | 5 | C0004238 | |
| Disease | total blood protein measurement | 7.85e-05 | 449 | 68 | 7 | EFO_0004536 | |
| Disease | immature platelet fraction | 1.42e-04 | 114 | 68 | 4 | EFO_0009187 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 1.45e-04 | 8 | 68 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | immature platelet measurement | 1.68e-04 | 119 | 68 | 4 | EFO_0803541 | |
| Disease | atrial fibrillation | 2.15e-04 | 371 | 68 | 6 | EFO_0000275 | |
| Disease | Premature atrial contractions | 2.82e-04 | 55 | 68 | 3 | HP_0006699 | |
| Disease | myeloid white cell count | 2.90e-04 | 937 | 68 | 9 | EFO_0007988 | |
| Disease | granulocyte percentage of myeloid white cells | 3.89e-04 | 268 | 68 | 5 | EFO_0007997 | |
| Disease | Prostatic Neoplasms | 5.38e-04 | 616 | 68 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.38e-04 | 616 | 68 | 7 | C0376358 | |
| Disease | body weights and measures, body height | 5.39e-04 | 15 | 68 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | Intellectual Disability | 5.79e-04 | 447 | 68 | 6 | C3714756 | |
| Disease | cardioembolic stroke | 6.50e-04 | 170 | 68 | 4 | EFO_1001976 | |
| Disease | factor XI measurement, Ischemic stroke | 6.96e-04 | 17 | 68 | 2 | EFO_0004694, HP_0002140 | |
| Disease | serum IgG measurement | 7.82e-04 | 18 | 68 | 2 | EFO_0004565 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 7.82e-04 | 18 | 68 | 2 | EFO_1000649, HP_0000131 | |
| Disease | platelet measurement | 8.08e-04 | 315 | 68 | 5 | EFO_0005036 | |
| Disease | factor VIII measurement, Ischemic stroke | 8.72e-04 | 19 | 68 | 2 | EFO_0004630, HP_0002140 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 9.68e-04 | 20 | 68 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | Headache, HbA1c measurement | 1.07e-03 | 21 | 68 | 2 | EFO_0004541, HP_0002315 | |
| Disease | alpha fetoprotein measurement | 1.61e-03 | 100 | 68 | 3 | EFO_0010583 | |
| Disease | platelet component distribution width | 1.75e-03 | 755 | 68 | 7 | EFO_0007984 | |
| Disease | immature platelet count | 1.91e-03 | 106 | 68 | 3 | EFO_0803544 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 2.18e-03 | 30 | 68 | 2 | EFO_0004629, HP_0002140 | |
| Disease | forced expiratory volume | 2.24e-03 | 789 | 68 | 7 | EFO_0004314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEDEEKKESSLPKSF | 806 | Q9UKV3 | |
| PSLREKEIKSTCKEE | 516 | P51826 | |
| IEPCKKRKKDDDTST | 21 | Q96QE3 | |
| DTKKIVLCDVEKPES | 86 | Q9UJX5 | |
| EEVTKAKPACKADKT | 786 | Q9UIF9 | |
| IKKEKDAESVECPDA | 296 | Q0JRZ9 | |
| VEETPKKCKDIIKTA | 106 | O75909 | |
| ECLKEPGKTSVESKV | 81 | O75952 | |
| SKDPSCVAKVSEEGK | 731 | Q4L235 | |
| SPSSCEVKKDELKSE | 1801 | Q9UKL3 | |
| EKSCASKEEVKEVSI | 521 | Q8WWK9 | |
| KPKKVECLEVETTDV | 141 | Q7Z5L2 | |
| FISKTPSKEEIEKEC | 31 | Q9Y2K5 | |
| SCPSDKEEEKSTKDV | 106 | Q9Y2K5 | |
| DSSKSCEIDPIKLKE | 431 | Q15283 | |
| EKVFDIPSDECIKIS | 211 | Q8N442 | |
| VLDCVSEKTKKDEAF | 166 | Q6ZW49 | |
| KETAESVLKKPVVDC | 126 | P34932 | |
| SVSPIEATEKCKKVE | 441 | Q9ULD2 | |
| SPEEAIKCEDKFTKS | 91 | P05198 | |
| TICEDIKSSKCKLPE | 771 | Q8NI77 | |
| PLSKIKFTGKECEDS | 1556 | Q8IY21 | |
| VCEEEKKTKTIDSVT | 331 | P08069 | |
| ACKEDIPSEKSEEIT | 26 | Q15121 | |
| LTQVEKECKEKEKPS | 166 | Q9HB71 | |
| TVEVPKDSKSKICSE | 816 | Q96Q89 | |
| ECLKEFVTPDTDIKV | 941 | P55160 | |
| ETEKEVKPVDSVKCP | 1226 | O60449 | |
| ESKGLEKVTCEPQKE | 911 | P23229 | |
| TVCFDVKLKSKEDTI | 701 | P56199 | |
| IVVEKKDPKKTCSVS | 96 | P08118 | |
| KSTITEIKECADEPV | 181 | Q92896 | |
| ICPKKDVLETFTVKS | 166 | P21926 | |
| FVPEKVEKVSKACKS | 2866 | Q9C0G6 | |
| CEECKKPIESDSKDL | 41 | Q5TD97 | |
| KTLPKQTFESETLEC | 156 | Q8NF50 | |
| SIIEKTCFLEEEKKT | 201 | Q5T0U0 | |
| SEEIGSDFKIKCEPK | 151 | P78310 | |
| SLCEDPFTLDEKKTE | 1076 | O75417 | |
| TSVPDICDKFKQITK | 281 | Q5TC63 | |
| CFKTSSENPLVIKKE | 121 | Q53FE4 | |
| VLSKPCKFEEKVSSE | 1481 | Q9C0D2 | |
| HKCDPEKETVEVSVK | 151 | Q9ULF5 | |
| CFEETKKEEIKEVPF | 601 | Q8WXH0 | |
| EKLEEAFSKSKSECT | 436 | Q7Z7B0 | |
| PKALKEESEDTCLET | 251 | Q5H9M0 | |
| EKVSEFPVIVESLKC | 106 | Q9NVN3 | |
| PVEETKKQKLSECSL | 26 | Q96PZ0 | |
| SISVEEFCEIEVKKP | 1146 | Q7Z333 | |
| EIKKVEFTDSPESRK | 31 | Q99697 | |
| KKESEEDKFPVCIRE | 61 | P48436 | |
| ECFVPDDKEEFVKAK | 36 | P13533 | |
| STLKCFVKEEDKPTL | 71 | A6NFN9 | |
| VKIKECKKSEDPTTP | 521 | Q96M02 | |
| EKEDSKVIPTECAIK | 276 | O14730 | |
| DERKPEVTCTLEDKK | 26 | Q96EI5 | |
| EKKASPEVKSCESFV | 96 | Q8IYI8 | |
| IKTSSDPTCVEKEKV | 111 | O14980 | |
| EKKASPEVKSCDSFV | 116 | Q9H0M5 | |
| CTIKDLLPKEKSSTE | 96 | Q9HCG1 | |
| SATECTLEKTDKDKF | 541 | Q9UBT6 | |
| EVKKSIDIPCKISST | 31 | A0A0A0MS01 | |
| DCVKDFTTREVKPEE | 31 | Q9Y5J7 | |
| EKSEKIPKESTTVTC | 871 | Q92576 | |
| CTLKDTEEVELKFPA | 671 | Q9UGP8 | |
| PPCSDSEEEVERKKK | 101 | O43159 | |
| VKTKEVPTKRSFECK | 61 | Q5T7W7 | |
| KEPVDTRVSCCKTKD | 776 | Q9BYW2 | |
| TLKKKCEESDSESPA | 386 | Q9H582 | |
| KAEDIKGTECVKSTP | 516 | Q96KR1 | |
| EKKASPEIKSCDSFV | 116 | Q9UC07 | |
| TVKTPKDKEEIVICD | 16 | Q9NRR5 | |
| DLESSCVTKKLSPEK | 46 | Q7Z3V5 | |
| KTCPKEDGDFVSDKI | 6 | O75132 |